Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

CCTV proposed at medical stores for sale of prescription drugs

Дата публикации: 17-09-2026 07:36:15

The move is aimed at strengthening oversight of the sale of prescription medicines and providing a mechanism to verify transactions in cases of suspected unauthorised sale

Основное содержимое страницы с новостью.

Under the existing Drugs Rules, medicines covered by Schedules H, H1 and X cannot be sold at retail without a prescription from a registered medical practitioner, with additional record-keeping requirements for certain drugs. Image for representation only

Under the existing Drugs Rules, medicines covered by Schedules H, H1 and X cannot be sold at retail without a prescription from a registered medical practitioner, with additional record-keeping requirements for certain drugs. Image for representation only | Photo Credit: K. Pichumani

The Union Health Ministry has proposed making CCTV surveillance mandatory at licensed premises selling prescription drugs, as part of proposed amendments to the Drugs Rules, 1945.

The draft notification, G.S.R. 791(E), issued on September 8, proposes inserting a new provision in Rule 65 requiring the supply of drugs on the prescription of a registered medical practitioner, other than through wholesale dealing, to take place under a CCTV surveillance system installed and maintained at the licensed premises. The recordings would have to be preserved for at least three months.

The proposal follows deliberations by the Drugs Consultative Committee (DCC) and subsequent consideration by the Drugs Technical Advisory Board (DTAB). The DCC had earlier recommended that CCTV cameras be made mandatory at medical stores and that they be positioned so that drug sales could be verified.

The move is aimed at strengthening oversight of the sale of prescription medicines and providing a mechanism to verify transactions in cases of suspected unauthorised sale. Under the existing Drugs Rules, medicines covered by Schedules H, H1 and X cannot be sold at retail without a prescription from a registered medical practitioner, with additional record-keeping requirements for certain drugs.

The draft, however, is not yet a final rule. The Ministry has invited objections and suggestions from affected persons and other stakeholders for 30 days from the date the Gazette was made available. The proposed rules will be considered after the expiry of this period.

The Ministry has said submissions may be sent to the Under Secretary (Drugs), Ministry of Health and Family Welfare, U-6, Work Hall-C Wing, First Floor, Kartavya Bhawan-1, New Delhi, or emailed to drugsdiv-mohfw@gov.in.

“The draft does not merely propose CCTV for Schedule H, H1 and X medicines by name. Its wording is broader — it covers any drug supplied on a registered medical practitioner’s prescription, except wholesale transactions,” said a senior health official.

Published - September 17, 2026 01:02 pm IST

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Аптеки смогут продавать лекарства онлайн без получения специального разрешения01022-09-2026
2Магазины начнут тщательнее отслеживать качество продуктов0515-07-2026
3"Известия": Росздравнадзор рекомендует усилить контроль за продажей рецептурных лекарств0024-03-2022
4"Известия": в ТПП предложили разрешить онлайн-ретейлерам продажу лекарств0023-06-2020
5МЭР предложило провести эксперимент по онлайн-продаже рецептурных лекарств0022-06-2021
6Медработникам в российских селах разрешили продавать лекарства0007-01-2022
7Госдума усилила уголовную ответственность за продажу поддельных лекарств через интернет0019-03-2020
8Путин утвердил ужесточение наказания за онлайн-продажу поддельных лекарств0001-04-2020
9Правительство предлагает разрешить только аптекам с допуском торговать через интернет0018-04-2020

Классификация: Общество. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.05. Источник: www.thehindu.com.